NCT00001410View on ClinicalTrials.gov

PEG-Glucocerebrosidase for the Treatment of Gaucher Disease

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

October 31, 1993

Study Completion Date

December 31, 2001

Conditions

Gaucher's Disease

Interventions

DRUG

Lysodase

Trial Locations (1)

20892

National Institute of Mental Health (NIMH), Bethesda

All Listed Sponsors

lead

National Institute of Mental Health (NIMH)

NIH